Moss 24.09.2018 Gentian Diagnostics AS announces today that one of its subsidiaries has entered into an..
Reference is made to the notice of the Extraordinary General Meeting issued by Gentian Diagnostics AS on 2..
Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 15 June 2018..
An extraordinary general meeting of Gentian Diagnostics AS, reg. no 983 860 516 (the "Company"), will be held..
GENTIAN DIAGNOSTICS AS HAS OBTAINED PROOF OF CONCEPT FOR A NEW PRODUCT FOR EXOCRINE PANCREATIC INSUFICIENCY..
Gentian Diagnostics AS: Directed share issue towards Vatne Equity and Norron
Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian..